China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

China flag China · Delayed Price · Currency is CNY
20.89
-0.32 (-1.51%)
Mar 9, 2026, 3:04 PM CST
-24.77%
Market Cap 10.70B
Revenue (ttm) 1.96B
Net Income (ttm) 327.25M
Shares Out 504.25M
EPS (ttm) 0.65
PE Ratio 32.62
Forward PE 18.81
Dividend 0.30 (1.41%)
Ex-Dividend Date Sep 26, 2025
Volume 5,237,166
Average Volume 4,251,450
Open 20.60
Previous Close 21.21
Day's Range 20.60 - 21.02
52-Week Range 20.56 - 30.76
Beta 0.21
RSI 32.70
Earnings Date Mar 21, 2026

About SHE:300294

China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. It offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. The company also provides bone peptide, oxytocin, heparin sodium, and posterior pituitary injection products. In addition, it engages in research, development, production, and sales of anti-infective, diabetes, and cardiovascular drug; and distributes bloo... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 1,938
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300294
Full Company Profile

Financial Performance

In 2024, SHE:300294's revenue was 1.73 billion, a decrease of -34.58% compared to the previous year's 2.65 billion. Earnings were 396.99 million, an increase of 67.18%.

Financial Statements

News

There is no news available yet.